My reply to the email I just got from Paul R. Please

New Post Public Reply Private Reply Replies (5) Message Board
CDiddy
875
My reply to the email I just got from Paul R.



Please take me off your list

On Tue, Aug 24, 2021, 7:23 PM Paul R <exitpoll@aol.com> wrote:
Dear CytoDyn Inc. stockholders:

First of all, thank you for your support so far.

We truly expect to win this election contest with your help.

We expect the management at CytoDyn to make many attempts to reach out to you prior to the upcoming annual meeting and it could get very confusing as we get close to Oct 28 (the announced annual meeting date). The main point is to vote our proxy on the white card that you will be getting by snail mail or email. Once you vote that white card you can be done as long as you do not fill out anything from the company. Best advice about any material you get from the company: do not respond to after reading. You can never go wrong by filing out any WHITE CARD YOU RECEIVE. Again, if you do fill out any Proxy from the company you will cancel out your vote for us. PLEASE DO NOT FILL OUT ANY PROXY MATERIAL FROM THE COMPANY!

Your vote is important, no matter how many shares of CytoDyn, Inc. ("CytoDyn" or "CYDY" you own. On behalf of the CYDY Investor Group, we recommend that stockholders vote on our WHITE proxy card or voting instruction form (the "WHITE CARD" that you receive “FOR ALL” of the Investor Group's highly qualified and very experienced nominees for the CYDY board.

You may vote by phone or Internet by following the instructions on the WHITE CARD that you receive. If you received your proxy card or voting instruction form by mail, you can also sign and return it in the enveloped enclosed with the WHITE CARD.

IF YOU HAVE ANY QUESTIONS AT ALL we encourage you to contact our proxy solicitor, Okapi Partners LLC, at +1 844-202-7428 (Toll Free).

Since this election is a contested proxy solicitation, if you do not give voting instructions to your broker, bank, or other custodian, your broker, bank, or other custodian will not be able to vote your shares with respect to the election of CYDY directors.

We urge you to instruct your broker, bank, or other custodian to vote your shares on the WHITE CARD.

We expect CytoDyn management will also send you proxy materials (when filed and available for distribution) and we urge you to discard any such materials.



In the event you make a mistake and return a proxy card or voting instruction form sent to you by CYDY management or current board, you can change your vote, by calling our Proxy company Okapi Partners LLC, at +1 844-202-7428 (Toll Free).



Only your latest-dated proxy card will count, so voting any card other than the WHITE CARD may change your vote.

Hope this note is helpful.

Please fill out our White Proxy and return immediately.

Thanks again for your support and help.

Sincerely,

PAUL R.

P.S. Tomorrow I will be sending you an email requesting the name of your brokers that hold your shares as well as asking you the number of shares you own and have or will vote. It is strictly for our Proxy firm to check with all the brokers to make sure all our shares have been voted.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Steel and TIER IV Unite for Autonomous Steel Transport

Updated Category News Views 357

Innovative Partnership for Autonomous Steel Transportation Nippon Steel Corporation, known as Japan's largest steel manufacturer, has initiated a significant collaboration with TIER IV, Inc., a trailblazer in the development of open-source software for autonomous driving. This partnership is set to revolutionize the way steel is transported within manufacturing...

Continue Reading
Brock Group Expands Leadership with New Regional Units

Updated Category News Views 303

The Brock Group Expands Leadership with New Regional Units The Brock Group is taking significant strides in enhancing its Brock Industrial Services (BIS) division. Recently, the company announced the creation of two new regional operating units designed to bolster its service capabilities and responsiveness for customers nationwide. Under this new organizational...

Continue Reading
Exploring Demand for Nasdaq-100 Index in Retirement Plans

Updated Category News Views 178

Rising Interest in Nasdaq-100 Index for Retirement Investments Recent findings reveal a burgeoning interest in the Nasdaq-100 Index among retirement plan participants. This trend signifies a noteworthy opportunity for retirement investment options catering to the needs of a modern workforce. A recent survey indicated that nearly 80 percent of 401(k) plan participants...

Continue Reading
ModivCare Securities Lawsuit Update: Key Details for Investors

Updated Category News Views 132

Important Updates Regarding ModivCare Lawsuit Levi & Korsinsky, LLP is reaching out to investors who have been part of ModivCare Inc. (NASDAQ: MODV) regarding a pivotal class action securities lawsuit. This notification signals a chance for investors affected by the Company’s alleged securities fraud to seek compensation. Understanding the Class Action Lawsuit The...

Continue Reading
Key Details for Nordic Fibreboard AS Annual Meeting Announcement

Updated Category News Views 163

Essential Details for the Upcoming Annual General Meeting The Annual General Meeting (AGM) of Nordic Fibreboard AS (registry code: 11421437) will be convened to discuss pivotal matters affecting the company's future. Set to take place at the headquarters in Pärnu, Estonia, the AGM is a prime opportunity for shareholders to engage directly with the company's management...

Continue Reading